Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
1.360
-0.080 (-5.56%)
At close: Oct 30, 2026, 4:00 PM EDT
1.350
-0.010 (-0.73%)
After-hours: Oct 30, 2026, 7:41 PM EDT
AARD's stock price has decreased by -88.14% in the past year and price targets may not have had time to catch up.
Aardvark Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +47.06% | Oct 26, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $6 → $2.5 | Hold | Maintains | $6 → $2.5 | +83.82% | Oct 23, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $3 | Sell | Maintains | $3 | +120.59% | Oct 23, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $4 → $1.5 | Sell | Reiterates | $4 → $1.5 | +10.29% | Oct 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Reiterates $6 | Hold | Reiterates | $6 | +341.18% | Aug 13, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.